Skip to main content

Animations

MJFF Publications

5051 - 5060 of 6509 Results
Title
Year
  • Year
  • 2023
  • 2016
  • 2019
  • 2020
  • 2023
  • 2022
  • 2016
  • 2025
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Lewy Body-like Pathology and Loss of Dopaminergic Neurons in Midbrain Organoids Derived from Familial Parkinson’s Disease Patient
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3390/cells12040625
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Interview with Mark Frasier: A Michael J Fox Foundation Perspective on Precision Medicine in Parkinson’S
    Journal Name: Personalized Medicine
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2217/pme-2016-0087
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Predicting Progression in Parkinson’s Disease Using Baseline and 1-Year Change Measures
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-181518
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Comparison of an Online-Only Parkinson’s Disease Research Cohort to Cohorts Assessed In Person
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-191808
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-223433
    Citation Count: 57
  • Summary Details
    OPEN
    Title: Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders
    Journal Name: ACS Applied Materials & Interfaces
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acsami.2c14220
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.07.013
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling and therapeutic implications
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1136/jnnp-2024-335364
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Revised criteria for the diagnosis and staging of Alzheimer’s disease
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41591-024-02988-7
    Citation Count: 149
  • Summary Details
    OPEN
    Title: Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.13859
    Citation Count: 1957
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.